UnitedHealth Group Incorporated (NYSE:UNH) Shares Purchased by McIlrath & Eck LLC

McIlrath & Eck LLC grew its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 8.2% in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 635 shares of the healthcare conglomerate’s stock after acquiring an additional 48 shares during the quarter. McIlrath & Eck LLC’s holdings in UnitedHealth Group were worth $371,000 as of its most recent SEC filing.

A number of other hedge funds have also recently modified their holdings of UNH. Kathleen S. Wright Associates Inc. acquired a new stake in shares of UnitedHealth Group during the 3rd quarter worth approximately $27,000. Macroview Investment Management LLC increased its stake in UnitedHealth Group by 671.4% during the second quarter. Macroview Investment Management LLC now owns 54 shares of the healthcare conglomerate’s stock worth $28,000 after acquiring an additional 47 shares during the last quarter. Global Wealth Strategies & Associates grew its holdings in shares of UnitedHealth Group by 152.4% during the 3rd quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock worth $31,000 after purchasing an additional 32 shares during the period. Signature Resources Capital Management LLC raised its holdings in UnitedHealth Group by 40.0% in the 2nd quarter. Signature Resources Capital Management LLC now owns 63 shares of the healthcare conglomerate’s stock valued at $32,000 after buying an additional 18 shares during the period. Finally, West Financial Advisors LLC acquired a new stake in UnitedHealth Group in the 3rd quarter valued at approximately $32,000. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Analysts Set New Price Targets

Several brokerages recently weighed in on UNH. TD Cowen upped their target price on shares of UnitedHealth Group from $601.00 to $609.00 and gave the stock a “buy” rating in a research note on Friday, October 18th. Cantor Fitzgerald upped their price target on UnitedHealth Group from $591.00 to $644.00 and gave the stock an “overweight” rating in a report on Wednesday, October 16th. Stephens lifted their price target on shares of UnitedHealth Group from $605.00 to $675.00 and gave the stock an “overweight” rating in a research note on Thursday, December 5th. Truist Financial reaffirmed a “buy” rating and set a $625.00 price objective (down from $640.00) on shares of UnitedHealth Group in a research report on Wednesday, October 16th. Finally, Royal Bank of Canada dropped their price target on shares of UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating on the stock in a research note on Wednesday, October 16th. Three investment analysts have rated the stock with a hold rating, eighteen have issued a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat, UnitedHealth Group currently has an average rating of “Moderate Buy” and an average target price of $626.84.

UnitedHealth Group Trading Up 0.8 %

Shares of UnitedHealth Group stock opened at $565.39 on Wednesday. The firm has a market cap of $520.31 billion, a price-to-earnings ratio of 36.83, a price-to-earnings-growth ratio of 1.65 and a beta of 0.58. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $630.73. The company’s 50-day simple moving average is $586.36 and its 200-day simple moving average is $559.39. The company has a quick ratio of 0.91, a current ratio of 0.91 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share for the quarter, topping analysts’ consensus estimates of $7.00 by $0.15. The business had revenue of $100.82 billion for the quarter, compared to analysts’ expectations of $99.14 billion. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The company’s revenue was up 9.2% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $6.56 EPS. As a group, equities research analysts anticipate that UnitedHealth Group Incorporated will post 27.6 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th will be issued a $2.10 dividend. This represents a $8.40 annualized dividend and a dividend yield of 1.49%. The ex-dividend date of this dividend is Monday, December 9th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 54.72%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.